Noven Pharmaceuticals Overview
- Founded
-
1987

- Status
-
Acquired/Merged
- Employees
-
300

- Latest Deal Type
-
M&A
- Financing Rounds
-
2
- Investments
-
4
Noven Pharmaceuticals General Information
Description
Manufacturer of prescription pharmaceutical products intended to patient care through transdermal drug delivery. The company is primarily focused on the areas of women's health and mental health, including ADHD and schizophrenia.
Contact Information
Website
www.noven.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Parent Company
Primary Office
- 11960 South West
- 144th Street
- Miami, FL 33186
- United States
+1 (305) 000-0000
Noven Pharmaceuticals Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Noven Pharmaceuticals Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Manufacturer of prescription pharmaceutical products intended to patient care through transdermal drug delivery. The com
Pharmaceuticals
Miami, FL
300
As of 2023
0000
0000-00-00
000000&0
Noven Pharmaceuticals Competitors (15)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Alkermes | Formerly VC-backed | Dublin, Ireland | 0000 | 00.000 | 000000000 | 00.000 |
0000 000000 | Private Debt Financed | Monmouth Junction, NJ | 000 | 000000000 - | ||
00000 | Corporation | Mumbai, India | 00000 | 00000000 | ||
000000 00000000 | Corporation | Tokyo, Japan | 00000 | 00.000 | 00000000 | 00.000 |
000000 00000000000 | Formerly PE-Backed | Oakville, Canada | 0 | 00000 | 000000&0 |
Noven Pharmaceuticals Patents
Noven Pharmaceuticals Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-11572339-B2 | Amphetamine carbamate compounds and methods | Active | 07-Jan-2021 | 0000000000 | 00 |
US-20220213029-A1 | Amphetamine carbamate compounds and methods | Active | 07-Jan-2021 | 0000000000 | |
US-20220218628-A1 | Transdermal amphetamine compositions with low levels of carbamate | Active | 07-Jan-2021 | 0000000000 | 0 |
US-11559501-B2 | Transdermal amphetamine compositions with low levels of carbamate | Active | 07-Jan-2021 | 0000000000 | 00 |
US-20190192662-A1 | Transdermal pharmaceutical compositions with reduced skin irritation | Inactive | 22-Dec-2017 | A61K47/22 |
Noven Pharmaceuticals Executive Team (6)
Noven Pharmaceuticals Board Members (1)
Name | Representing | Role | Since |
---|---|---|---|
00000000 0000 | Noven Pharmaceuticals | Chairman & Chief Executive Officer | 000 0000 |
Noven Pharmaceuticals Signals
Noven Pharmaceuticals Investments & Acquisitions (4)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
000 000000000 | 15-Aug-2007 | 0000000000 | 00000 | Pharmaceuticals | |
0000000 00000 | 20-Mar-2007 | 00000 0000 | 0000 | Surgical Devices | 000000 00 |
0000000 00000 | 31-Jan-2003 | 00000 0000 | 0000 | Surgical Devices | 000000 00 |
Salient Surgical Technologies | 15-Jan-2002 | Later Stage VC | 000.00 | Surgical Devices | 000000 00 |
Noven Pharmaceuticals Exits (3)
Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
---|---|---|---|---|---|
0000000 00000000 0 | 20-Mar-2007 | 00000 00000 00 | 0000 | Completed |
|
0000000 00000000 0 | 31-Jan-2003 | 00000 00000 00 | 0000 | Completed |
|
Salient Surgical Technologies | 15-Jan-2002 | Later Stage VC | 000.00 | Completed |
|